Biologist

Health Researcher

• 2015: PhD in Oncology and Experimental Pathology at the University of Bologna.
• 2011: Master’s Degree in Biology of Health at the University of Bologna (final grade: 110/110 cum laude).
• 2008: Bachelor’s Degree in Biology at the University of Bologna (final grade: 107/110).

2012: Ability to exert the profession of Biologist

• 2019 - today: Researcher in Health at Laboratorio di Oncologia Sperimentale 
• 2018 – 2019: Member of the Research Staff (as Co. Co. Co) of the Laboratorio di Oncologia Sperimentale
• 2016 – 2018: Associazione Italiana Ricerca sul Cancro (AIRC) triennial fellow at Laboratorio di Oncologia Sperimentale. Project: Dissecting the role of insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) in the malignancy of Ewing sarcoma.  
• 2017: Research activity as awardee of the Guido Berlucchi Foundation young researchers Mobility Programme at Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School (Worcester, MA, USA) during 6 months. Project: Assessment of the insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) mRNA targets and their implication in the malignancy of Ewing sarcoma. 
• 2012-2015: PhD student in Oncology and Experimental Pathology, University of Bologna at Laboratorio di Oncologia Sperimentale. Project: IGF system, CD99 molecule, tumor-specific chromosomal translocations: evaluation of their prognostic value in prostate cancer and Ewing sarcoma 
• 2012: Abroad research experience at Molecular Biology Laboratory, Instituto Valenciano de Oncologia, Valencia (SPAIN) as awardee of Marco Polo Programme. Project: IGF system, CD99 molecule, tumor-specific chromosomal translocations: evaluation of their prognostic value in prostate cancer.    
• 2011: Research fellow at Laboratorio di Oncologia Sperimentale, IRCCS Istituto Ortopedico Rizzoli, Bologna. 
• 2010 - 2011: Internal student at Laboratorio di Oncologia Sperimentale, IRCCS Istituto Ortopedico Rizzoli, Bologna. Project: Molecular mechanisms at the basis of resistance to new insulin-like growth factor 1 receptor targeted therapy
• 2008 : Internal student in Biochemistry Laboratory, University of Bologna, Bologna. Project: Characterization of fibroblasts mitochondrial functions in monkeys affected by optic neuropathy.

Italian: mother tongue
English: fluent
Spanish: scholastic

Excellent knowledge of computer tools including Microsoft Office (Word, Excel, PowerPoint), SPSS, NIS-Element, Quantity One, Graph Pad

Collaborator of Research Projects funded by: AIRC and  Ministry of Health (Finalized Research)
Awards:

• 2023: Travel fellowship for attendance as speaker to IGF Gordon Research Conference. Ventura, CA, USA. 
• 2017: Travel fellowship for attendance to 2nd Faris D. Virani International Ewing Sarcoma Conference. Houston, TX, USA.
• 2016: Travel fellowship from Italian Cancer Society (SIC) for attendance to 58th Annual Meeting of SIC (Italian Cancer Society). Verona, Italy.
• 2016: Award for the best research project in Ewing sarcoma from Italian Association of Cell Cultures (AICC) through the contribution of “Un sorriso con Luca” association. Project: Dissecting the role of insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) in the malignancy of Ewing sarcoma.
• 2016: AACR-SIC Scholar-in-Training Award travel grant from AACR (American Association for Cancer Research) and SIC (Italian Cancer Society) to attend the AACR Annual Meeting 2016. New Orleans, LA, USA.
• 2013: Travel fellowship from Italian Cancer Society (SIC) for attendance to 55th Annual Meeting of SIC – Catanzaro, Italy. 

Scientific production: author and co-author of 18 international publications in Pubmed e Scopus. H-index: 11 (Scopus). Communications at national and international scientific congresses.

Participation to scientific associations: Società Italiana di cancerologia (SIC), European Association for Cancer Research (EACR), Associazione Italiana di Colture Cellulari (AICC), American Association for Cancer Research (AACR). Reviewer for international scientific journals.

Study of post-transcriptional mechanisms of gene expression regulation mediated by RNA-binding proteins in the malignancy of sarcomas.
Identification of prognosis biomarkers in sarcomas.
Molecular mechanisms at the basis of resistance to new insulin-like growth factor 1 receptor targeted therapy.